Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation

Cardiovascular Research

Volumn 42, Issue 2, 1999, Pages 443-454

  Brundel, Bianca J J M ^a   Van Gelder, Isabelle C ^a   Henning, Robert H ^a   Tuinenburg, Anton E ^a   Deelman, Leo E ^a   Tieleman, Robert G ^a   Grandjean, Jan G ^a   Van Gilst, Wiek H ^a   Crijns, Harry J G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Atrial fibrillation; Ca2+ handling proteins; Gene expression

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; COMPLEMENTARY DNA; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PHOSPHOLAMBAN; RNA; RYANODINE RECEPTOR;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CALCIUM HOMEOSTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; GENE EXPRESSION; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT ATRIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; RNA ANALYSIS; SODIUM CALCIUM EXCHANGE;

AGED; ATRIAL FIBRILLATION; BLOTTING, WESTERN; CALCIUM; CALCIUM CHANNELS; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; ELECTROPHORESIS, AGAR GEL; FEMALE; GENE EXPRESSION; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; PROTEIN ISOFORMS; RNA, MESSENGER; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; SODIUM-CALCIUM EXCHANGER; TIME FACTORS;

EID: 0033052270     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00045-0     Document Type: Article

References (31)

1. Kannel W.B., Abbott R.D., Savage D.D., McNamara P.M. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 306:1982;1018-1022.
2. Manning W.J., Silverman D.I., Katz S.E., et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol. 23:1994;1535-1540.
3. Van Gelder I.C., Crijns H.J., Blanksma P.K., et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol. 72:1993;560-566.
4. Bailey G.W.H., Braniff B.A., Hancock E.W., Cohn K.E. Relation of left atrial pathology to atrial fibrillation in mitral valvular disease. Ann Intern Med. 69:1968;13-20.
5. Ausma J., Wijffels M., Thone F., Wouters L., Allessie M., Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation. 96:1997;3157-3163.
6. Wijffels M.C., Kirchhof C.J., Dorland R., Allessie M.A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 92:1995;1954-1968.
7. Leistad E., Aksnes G., Verburg E., Christensen G. Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644. Circulation. 93:1996;1747-1754.
8. Lee H.C., Clusin W.T. Cytosolic calcium staircase in cultured myocardial cells. Circ Res. 61:1987;934-939.
9. De Pauw M., Borgers M., Heyndrickx G.R. Ultrastuctural calcium distribution in cardiac myocytes after 48 h of rapid pacing in dogs [abstract]. Circulation. 94:1996;I-604.
10. 2+ current in frog ventricular myocytes by the holding potential, cAMP and frequency. Pfluger's Arch. 415:1989;1-11.
11. Yue L., Feng J., Gaspo R., Li G.R., Wang Z., Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res. 81:1997;512-525.
12. Van Wagoner D.R., Lamorgese M., Kirian P., Cheng Y., Efimov I.R., Mazgalev T.N. Calcium current density is reduced in atrial myocytes isolated from patients in chronic atrial fibrillation [abstract]. Circulation. 96:1997;I-180.
13. Daoud E.G., Knight B.P., Weiss R., et al. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. Circulation. 96:1997;1542-1550.
14. Sun H., Gaspo R., Leblanc N., Nattel S. Cellular mechanism of atrial contractile dysfunction caused by sustained atrial tachycardia. Circulation. 98:1998;719-727.
15. Van Gelder IC, Brundel BJJM, Henning RH, et al. Alterations in gene expression of proteins involved in the calcium handling in patients with atrial fibrillation. J Cardiovasc Electrophysiol 1999:in press.
16. Gallagher M.M., Camm A.J. Classification of atrial fibrillation. Pacing Clin Electrophysiol. 20:1997;1603-1605.
17. Levy S., Breithardt G., Campbell R.W., et al. Atrial fibrillation: current knowledge and recommendations for management. Eur Heart J. 19:1998;1294-1320.
18. Yue L., Wang Z., Gaspo R., Nattel S. The molecular mechanism of ionic remodeling of repolarization in a dog model of atrial fibrillation [abstract]. Circulation. 96:1998;I-180.
19. 2+-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest. 85:1990;305-309.
20. 2+-ATPase in failing and nonfailing human myocardium. Circ Res. 75:1994;434-442.
21. 2+-ATPase in failing and nonfailing human hearts. Cardiovasc Res. 31:1996;625-632.
22. 2+ exchanger in end-stage human heart failure. Circ Res. 75:1994;443-453.
23. Meyer M., Schillinger W., Pieske B., et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation. 92:1995;778-784.
24. 2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy. J Mol Med. 74:1996;321-332.
25. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation. 90:1994;653-657.
26. 2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation. 92:1995;3220-3228.
27. Tunwell R.E., Wickenden C., Bertrand B.M., et al. The human cardiac muscle ryanodine receptor-calcium release channel: identification, primary structure and topological analysis. Biochem J. 318:1996;477-487.
28. Diebold R.J., Koch W.J., Ellinor P.T., et al. Mutually exclusive exon splicing of the cardiac calcium channel alpha 1 subunit gene generates developmentally regulated isoforms in the rat heart. Proc Natl Acad Sci USA. 89:1992;1497-1501.
29. Feron O., Octave J.N., Christen M.O., Godfraind T. Quantification of two splicing events in the L-type calcium channel alpha-1 subunit of intestinal smooth muscle and other tissues. Eur J Biochem. 222:1994;195-202.
30. Gidh J.M., Huang B., Jain P., Battula V., El Sherif N. Reemergence of the fetal pattern of L-type calcium channel gene expression in non infarcted myocardium during left ventricular remodeling. Biochem Biophys Res Commun. 216:1995;892-897.
31. Ausma J., Wijffels M., Van Eys G., et al. Dedifferentiation of atrial cardiomyocytes as a result of chronic atrial fibrillation. Am J Pathol. 151:1997;985-997.